| Balance Sheet Components |
Balance Sheet Components Inventory The components of inventory are summarized as follows (in thousands): | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | Raw materials | $ | 15,931 | | | $ | 5,047 | | | Work in progress | 8,781 | | | 5,033 | | | Finished goods | 14,167 | | | 12,554 | | | Total inventory | $ | 38,879 | | | $ | 22,634 | |
Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands): | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | Prepaid co-pay assistance program and rebates | $ | 16,774 | | | $ | 9,485 | | | Prepaid clinical trial costs | 2,786 | | | 2,577 | | | Other prepaid expenses and current assets | 15,210 | | | 9,017 | | | Total prepaid expenses and other current assets | $ | 34,770 | | | $ | 21,079 | |
Accrued Liabilities Accrued liabilities consist of the following (in thousands): | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | Accrued sales deductions | $ | 107,754 | | | $ | 78,308 | | | Accrued compensation | 15,507 | | | 20,533 | | | Accrued Ducentis milestone | 9,198 | | | — | | | Accrued expenses and other current liabilities | 14,327 | | | 17,469 | | | Total accrued liabilities | $ | 146,786 | | | $ | 116,310 | |
|